A brief review of pharmacokinetic assessments of vancomycin in special groups of patients with altered pharmacokinetic parameters.
Sign Up to like & getrecommendations! Published in 2022 at "Current drug safety"
DOI: 10.2174/1574886317666220801124718
Abstract: Vancomycin is considered the drug of choice against many Gram-positive bacterial infections. Therapeutic drug monitoring (TDM) is essential to achieve an optimum clinical response and avoid vancomycin-induced adverse reactions including nephrotoxicity. Although different studies are… read more here.
Keywords: special groups; vancomycin; patients altered; pharmacokinetic assessments ... See more keywords